CSX Corp (NASDAQ:CSX) shares traded 1.25% higher at $35.78 on Wall Street last session.
CSX stock price is now 3.78% away from the 50-day moving average and 3.22% away from the 200-day moving average. The market capitalization of the company currently stands at $69.86B.
With the price target reduced from $36 to $35, TD Cowen maintained Hold rating for CSX Corp (NASDAQ: CSX). On October 09, 2024, Citigroup recently initiated its ‘Buy’ rating on the stock quoting a target price of $42, while ‘BofA Securities’ rates the stock as ‘Neutral’
In other news, Goldman Nathan D, EVP & CLO sold 118,588 shares of the company’s stock on Nov 18 ’24. The stock was sold for $4,197,315 at an average price of $35.39. Upon completion of the transaction, the EVP & CLO now directly owns 202,991 shares in the company, valued at $7.26 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 18 ’24, Officer Goldman Nathan D bought 118,588 shares of the business’s stock. A total of $4,198,010 was incurred on buying the stock at an average price of $35.40. A total of 0.15% of the company’s stock is owned by insiders.
During the past 12 months, CSX Corp has had a low of $31.65 and a high of $40.12. As of last week, the company has a debt-to-equity ratio of 1.47, a current ratio of 1.39, and a quick ratio of 1.23. According to the stock market information, the enterprise value for the company is $86481838080, which is based on a 19.23 price-to-earnings ratio, a 2.43 price-to-earnings-growth ratio, and a beta of 1.19. The fifty day moving average price for CSX is $34.4772 and a two-hundred day moving average price translates $34.6639 for the stock.
The latest earnings results from CSX Corp (NASDAQ: CSX) was released for 2024-09-30. The net profit margin was 24.77% and return on equity was 29.23% for CSX. The company reported revenue of $3.62 billion for the quarter, compared to $3.57 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 1.32 percent.